Exponent (EXPO) Group Vice President receives 4,454 RSU compensation grant

Rhea-AI Filing Summary

Exponent Inc reported that Group Vice President James Bradley A received a grant of 4,454 Restricted Stock Units (RSUs) on March 13, 2026. These RSUs represent rights to receive an equal number of shares of common stock on a 1-for-1 basis.

The grant is a compensation-related award at no purchase cost, rather than an open-market transaction. Following this award, Bradley holds 4,454 RSUs directly. The RSUs are scheduled with an exercise and expiration date of March 13, 2030, indicating the expected settlement period for the underlying common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider James Bradley A

Role Group Vice President

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units	4,454	$0.00	--

Holdings After Transaction: Restricted Stock Units — 4,454 shares (Direct)

Footnotes (1)

1. 1-for-1. Not applicable.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

James Bradley A

(Last) (First) (Middle)

149 COMMONWEALTH DRIVE

(Street)

MENLO PARK CA 94025

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
EXPONENT INC [ EXPO ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Group Vice President

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/13/2026		A		4,454		03/13/2030	03/13/2030	Common Stock	4,454	(2)	4,454	D

Explanation of Responses:

1. 1-for-1.

2. Not applicable.

	By: Wendy Whitehouse For: Bradley A. James	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Exponent (EXPO) insider James Bradley receive in this Form 4?

James Bradley received a grant of 4,454 Restricted Stock Units (RSUs) as compensation. Each RSU represents the right to receive one share of Exponent common stock in the future, without paying a purchase price in the market.

Is the Exponent (EXPO) Form 4 transaction a stock purchase or sale?

The Form 4 for Exponent shows a grant of RSUs, not a market purchase or sale. The transaction code is “A,” meaning a grant or award acquisition, so no open-market buy or sell occurred in this filing.

How many Exponent (EXPO) RSUs does James Bradley hold after this filing?

After the reported grant, James Bradley holds 4,454 Restricted Stock Units. These RSUs give him the right to receive 4,454 shares of Exponent common stock in the future, subject to the award’s terms and any applicable vesting conditions.

What do the exercise and expiration dates mean in this Exponent (EXPO) Form 4?

The RSUs show an exercise and expiration date of March 13, 2030. This date indicates the expected timeframe by which the RSUs convert into common stock or lapse, depending on the specific terms of the compensation award.

What does the 1-for-1 footnote mean for Exponent (EXPO) RSUs?

The footnote stating “1-for-1” means each Restricted Stock Unit corresponds to one share of Exponent common stock. When the RSUs settle, Bradley can receive up to 4,454 shares, assuming all units vest and are delivered under the plan.

Does this Exponent (EXPO) Form 4 indicate any remaining derivatives or options for James Bradley?

The filing shows this single RSU grant and an empty derivative summary. Based on the provided data, the only derivative position reported here is the 4,454 RSUs awarded on March 13, 2026, with no additional derivative holdings listed.